Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Batchelor

Showing results (301-310 of 321) with videos related to

Pageof 33
Sort By:
Nature Medicine|July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue samplingKirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
JCO Precision Oncology|September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent GlioblastomaAndrew S Chi, Daniel P Cahill, David A Reardon, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Nature Communications|December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohortJ Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Blood|March 17, 2026
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) StudyLeon D Kaulen, Lakshmi Nayak, Philipp Karschnia, et al.
Science (New York, N.Y.)|April 21, 2018
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seqMariella G Filbin, Itay Tirosh, Volker Hovestadt, et al.
Pageof 33

Showing results (301-310 of 321) with videos related to

Sort By:
Pageof 33
Nature Medicine|July 24, 2023
Correcting the drug development paradigm for glioblastoma requires serial tissue samplingKirit Singh, Kelly M Hotchkiss, Ian F Parney, et al.
JCO Precision Oncology|September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent GlioblastomaAndrew S Chi, Daniel P Cahill, David A Reardon, et al.
Acta Neuropathologica Communications|January 16, 2015
Sporadic hemangioblastomas are characterized by cryptic VHL inactivationGanesh M Shankar, Amaro Taylor-Weiner, Nina Lelic, et al.
Blood|May 22, 2024
Rapid tumor DNA analysis of cerebrospinal fluid accelerates treatment of central nervous system lymphomaMihir Gupta, Joseph D Bradley, Elie Massaad, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2018
Genotype-targeted local therapy of gliomaGanesh M Shankar, Ameya R Kirtane, Julie J Miller, et al.
Nature Communications|December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohortJ Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Neuro-Oncology|April 25, 2020
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directionsPatrick Y Wen, Michael Weller, Eudocia Quant Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control DataTulika Rudra Gupta, Mei-Yin C Polley, Robert Redd, et al.
Blood|March 17, 2026
Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) StudyLeon D Kaulen, Lakshmi Nayak, Philipp Karschnia, et al.
Science (New York, N.Y.)|April 21, 2018
Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seqMariella G Filbin, Itay Tirosh, Volker Hovestadt, et al.
Pageof 33